ACE p.Ala154Val
c.461C>T · VCV3582433
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1846 | likely benign |
|---|---|---|
| REVEL | 0.174 | moderately benign-leaning |
| SaProt | LLR -10.42 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 1.9 | GERP 0.28, phastCons 1 |
| Regional constraint | o/e 1.04 | unconstrained · MANE · 20 kb · p 0.13 · regional, not allelic |
| Overall | ||
| CADD | 21.5 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.00446% | 22,416 |
| Admixed American | 0.00167% | 59,974 |
| African / African-American | 0.00133% | 74,952 |
| European (non-Finnish) | 8.48e-05% | 1,179,894 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ACE
- Protein
- p.Ala154Val
- Coding
- c.461C>T
- MANE Select
- NM_000789
- Type
- single nucleotide variant
- Location
- chr17:63479050 (GRCh38)
- Gene constraint
- LOEUF 0.88 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 91.38 · 97 PDB
- Residue 154
- a UniProt-annotated variant site (in); the peptidase m2 1 domain
Similar variants
- ACE p.Ala154Thr Benign ★★ ⚠ same residue
- ACE c.1342+1G>T Likely pathogenic ★★ same condition
- ACE c.3503+1G>C Likely pathogenic ★★ same condition
- ACE c.945+2T>G Likely pathogenic ★★ same condition
- ACE p.Arg265Ter Pathogenic ★★ same condition
- ACE p.Arg508Ter Pathogenic ★★ same condition
- ACE p.Arg791Ter Pathogenic ★★ same condition
- ACE p.Gln396Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ace-p-ala154val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown